Non-Small Cell Lung Cancer (NSCLC) News Monitoring

US FDA grants breakthrough therapy designation to sacituzumab tirumotecan to treat certain patients with previously ...

Merck, known as MSD outside of the United States and Canada, announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to sacituzumab tirumotecan (sac-TMT) for the treatment of patients with advanced or …

FDA Grants Breakthrough Therapy Designation to Sacituzumab Tirumotecan for EGFR+ NSCLC

The FDA has granted breakthrough therapy designation to sacituzumab tirumotecan (SKB264/MK-2870) for use as a potential option in patients with advanced or metastatic nonsquamous non–small cell lung cancer (NSCLC) harboring EGFR mutations whose disease …

FDA Grants Breakthrough Therapy Designation to Sac-TMT for Some with NSCLC

The Food and Drug Administration (FDA) has granted a breakthrough therapy designation to the antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT, also known as MK-2870 and SKB264) for the treatment of certain patients with advanced or metastatic …

Akeso's Cadonilimab (PD-1/CTLA-4 Bispecific Antibody) Combination Therapy For PD-(L)1 Resistant NSCLC Showcased In Oral ...

Analysis of the Effects of Bevacizumab Combined with Chemoradiotherapy on VEGF, bFGF, and Let-7 Levels in Non-Small Cell ...

Introduction Lung cancer stands as a formidable health challenge, characterized by a substantial incidence rate and an alarming mortality rate. Indeed, it has emerged as the leading cause of cancer-associated deaths worldwide. Among the diverse subtypes, …

Disparities Impact Access to Minimally Invasive Surgery for NSCLC

Photo Credit: Anyaberkut Disparities in minimally invasive surgery for early NSCLC are influenced by demographic and patient-specific factors, according to results published in JTCVS Open. Aminah Sallam, MD, and colleagues examined receipt of minimally …

ImPact Biotech Presents Updated Interim Phase 3 Data from ENLIGHTED Study of Padeliporfin VTP in Low Grade UTUC at SUO ...

-- Complete response (CR) observed in 85% (17/20) of evaluable patients with low-grade upper tract urothelial cancer (UTUC) who completed the Induction Treatment Phase -- -- Padeliporfin VTP treatment continues to be safe and efficacious, establishing …

Cancer Biologics Market Analysis | Worth USD 195.5 Billion by 2032, Growing at 7.5% During 2023-2032 | SNS Insider

Market Growth Driven by Increasing Incidence of Cancer and Technological Advancements in Biologic Therapies; Research and Regulatory Support by Governments. AUSTIN, TX, UNITED STATES, December 4, 2024 /⁨EINPresswire.com⁩/ -- According to SNS …

The big rebrand: Why these 4 biopharmas changed their name this year

What’s in a name? For pharmaceutical and biotech companies, a lot. The past 12 months have seen a spate of companies changing their names to better reflect their mission, focus and vision. The year kicked off with the biggest among them when J&J shed …

Algorithm Exposes Cells Driving Aggressive Tumor Growth

Register for free to listen to this article Thank you. Listen to this article using the player above. ✖ Want to listen to this article for FREE? Complete the form below to unlock access to ALL audio articles. The first computer algorithm capable of …

Nemvaleukin Shows Manageable Safety Profile in Advanced Solid Tumors

Treatment with nemvaleukin in patients with advanced solid tumors was shown to have promising antitumor activity and was well-tolerated. The phase 1/2 ARTISTRY-1 study, published in the Journal for ImmunoTherapy of Cancer, included 243 patients with …

High-Dose Vitamin C Improves Outcomes for Late-Stage Pancreatic Cancer

Adding high dose, intravenous (IV) vitamin C to chemotherapy could potentially double the overall survival among individuals with late-stage metastatic pancreatic cancer from 8 to 16 months, according to research findings published in Redox Biology. The …

Baseline Response Rates Inform Immunotherapy Sequencing in NSCLC

For patients who have non–small cell lung cancer (NSCLC) and have received immunotherapy with an immune checkpoint inhibitor (ICI), the investigators of a new study suggest that a baseline response rate of 10% could be used to gauge the ongoing …

p53 isoforms have a high aggregation propensity, interact with chaperones and lack binding to p53 interaction partners

The tumor suppressor p53 is the most mutated protein in cancer cells with more than 2000 different mutations identified so far (1). In tumor cells with wild type p53, its activity is also inhibited e.g. by the overexpression of E3 ligases such as Mdm2 (2,3 …

Gilead looks beyond Trodelvy with Tubulis alliance

Gilead Sciences has shored up its antibody-drug conjugate pipeline by licensing a candidate from German biotech Tubulis in a deal worth up to $415 million. The agreement includes an upfront payment of $20 million to Munich-based Tubulis for opt-in rights …

Clinical Outcomes of SBRT and Chemoradiotherapy for Locally Advanced NSCLC

Photo Credit: freepik The following is a summary of “Primary lung tumour stereotactic body radiotherapy followed by concurrent mediastinal chemoradiotherapy and adjuvant immunotherapy for locally advanced non-small-cell lung cancer: a multicentre, single- …

Why Is Coherus BioSciences Stock Trading Higher On Tuesday?

On Tuesday, Coherus BioSciences, Inc. CHRS entered into an asset purchase agreement with Intas Pharmaceuticals Ltd for the divestiture of the Udenyca (pegfilgrastim-cbqv) franchise for up to $558.4 million. The deal consideration includes an upfront …

Precision Oncology: Expanding Therapeutic Horizons With Trastuzumab Deruxtecan

Abstract Precision medicine has revolutionized cancer treatment by targeting shared genetic markers and shifting oncology care away from traditional cancer type–specific approaches. The targeted therapy fam-trastuzumab deruxtecan-nxki (Enhertu; T-DXd; …

Gilead Plots ADC Comeback with Potential $465M License Agreement

Gilead Sciences on Tuesday put forth $20 million in an exclusive option and license agreement with Tubulis to advance novel antibody-drug conjugate therapies for solid tumors. Aside from the upfront payment, Gilead is also on the hook for a $30 million …

Curity to Participate in Gartner's Identity & Access Management Summit 2024

Curity, an innovator in CIAM and API access security, will be at the Gartner Identity and Access Management Summit 2024, Dec 9-11 in Grapevine, Texas. AUSTIN, TX, UNITED STATES, December 4, 2024 /⁨EINPresswire.com⁩/ -- Curity, an innovator in …

Avalue Announces AI Edge Platform for Automotive, Industrial, Medical Applications, Powered by NVIDIA Jetson Family

New AI Edge Platform Series AIB-NINX-S, AIB-NINX-SC, AIB-NIAO-S offers integrated AI SDK, HW, and I/O to drive integrated solutions development TAIPEI, TAIWAN, December 4, 2024 /⁨EINPresswire.com⁩/ -- Avalue Technology Inc. (TAIEX: 3479-TW), …

Woligo Launches Affiliate Program to Help Financial Professionals Promote Income Protection

OKLAHOMA CITY, OK, UNITED STATES, December 4, 2024 /⁨EINPresswire.com⁩/ -- Woligo, a leading provider of insurance and benefit solutions, is excited to launch its new Affiliate Marketing Program for financial professionals across the country - …

Desert Star Institute for Family Planning Celebrates One Year of Community Impact Following Historic Transition

PHOENIX, AZ, UNITED STATES, December 4, 2024 /⁨EINPresswire.com⁩/ -- This month marks the one-year anniversary of the transformation of Desert Star Family Planning into the nonprofit Desert Star Institute for Family Planning, led by Dr. DeShawn …

Biovenic: Driving Innovation in Animal Breeding for a Sustainable Future

Biovenic stands out in today's world when animal breeding is paramount to providing versatile breeding solutions for agricultural companies and researchers. HAUPPAUGE, NY, UNITED STATES, December 4, 2024 /⁨EINPresswire.com⁩/ -- Biovenic: …

Confidential and Comprehensive Rehab for Professional Women in Texas

Professional women often face unique challenges in their careers, and many turn to unhealthy coping mechanisms such as substance abuse to manage stress... KERRVILLE, TX, UNITED STATES, December 4, 2024 /⁨EINPresswire.com⁩/ -- Professional women …

Nano Gold in India Market Trend | Explore the Future Growth Opportunities by 2027

The India nano gold market size is projected to reach $499.7 million by 2027, growing at a CAGR of 17.0% from 2020 to 2027 WILMINGTON, DE, UNITED STATES, December 4, 2024 /⁨EINPresswire.com⁩/ -- The India nano gold market was estimated at $201.4 …

K2view Shines as Visionary in 2024 Gartner Magic Quadrant for Data Integration Tools

K2view is named a "Visionary" for the second consecutive year, achieving significant gains in Ability to Execute ratings PALO ALTO, CA, UNITED STATES, December 4, 2024 /⁨EINPresswire.com⁩/ -- K2view, a global leader in data management …

Voices of Hope for BCYW: Insights into Emotional Health & Research Innovations Inspired by Brave Young Women Testimonies

Personal Testimonies of Young Women Breast Cancer Survivors Shaping Emotional Health and New Research Directions for BCYW Foundation DENVER, CO, UNITED STATES, December 4, 2024 /⁨EINPresswire.com⁩/ -- The recent International Conference on Young …

Groundbreaking Breast Cancer Treatment Wins 2024 Create the Future Design Contest

NEW YORK, NY, UNITED STATES, December 4, 2024 /⁨EINPresswire.com⁩/ -- The Grand Prize in the 2024 Create the Future Design Contest was awarded to Sam Currier and Priyan Weerrappuli from the University of Michigan for their novel injectable …

Exergen Corporation Names Katia Da Silva Almeida Jovino as New Sales Representative for Brazil

Exergen Corporation Names Katia Da Silva Almeida Jovino as New Sales Representative for Brazil WATERTOWN, MA, UNITED STATES, December 4, 2024 /⁨EINPresswire.com⁩/ -- WATERTOWN, Mass. – December 4, 2024 – Exergen Corporation, the leading …

Thoropass penetration testing service joins elite group in being CREST accredited

Thoropass’ pentesting service recognized as best in class alongside an exclusive group of global providers NEW YORK, NY, UNITED STATES, December 4, 2024 /⁨EINPresswire.com⁩/ -- Thoropass, the global leading infosec compliance delivery platform, …

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Market To Reach USD 282.81 Million by 2034 At Rate Of 7.6%

The growing existence of BPDCN and the progression in diagnostic techniques are driving the market. NEW YORK CITY, NY, UNITED STATES, December 4, 2024 /⁨EINPresswire.com⁩/ -- Our blastic plasmacytoid dendritic cell neoplasm (BPDCN) market report …

Global Omega-3 Market Outlook 2024-2033: Growth Drivers, Share, And Trends

The Business Research Company’s Early Year-End Sale! Get up to 30% off detailed market research reports—for a limited time only! LONDON, GREATER LONDON, UNITED KINGDOM, December 4, 2024 /⁨EINPresswire.com⁩/ -- The Business Research Company’s Early …

Oncology Nutrition Market Report 2024: Size, Trends, and Growth Insights for Global Expansion

The Business Research Company’s Early Year-End Sale! Get up to 30% off detailed market research reports—for a limited time only! LONDON, GREATER LONDON, UNITED KINGDOM, December 4, 2024 /⁨EINPresswire.com⁩/ -- The Business Research Company’s …

Oral Care Market Forecast 2024-2033: Analyzing Growth Drivers, Market Share, Segments, and Emerging Trends

The Business Research Company’s Early Year-End Sale! Get up to 30% off detailed market research reports—for a limited time only! LONDON, GREATER LONDON, UNITED KINGDOM, December 4, 2024 /⁨EINPresswire.com⁩/ -- The Business Research Company’s …

Oral Thin Films Global Market 2024 To Reach $7.65 Billion By 2028 At Rate Of 13.6%

The Business Research Company’s Early Year-End Sale! Get up to 30% off detailed market research reports—for a limited time only! LONDON, GREATER LONDON, UNITED KINGDOM, December 4, 2024 /⁨EINPresswire.com⁩/ -- The Business Research Company’s Early …

Rising Geriatric Population Drives Growth: Primary Driver in the Orthopedic Power Tools Market 2024

The Business Research Company’s Early Year-End Sale! Get up to 30% off detailed market research reports—for a limited time only! LONDON, GREATER LONDON, UNITED KINGDOM, December 4, 2024 /⁨EINPresswire.com⁩/ -- The Business Research Company’s Early …

Orthopedic Regenerative Surgical Products Global Market 2024 To Reach $6.4 Billion By 2028 At Rate Of 8.3%

The Business Research Company’s Early Year-End Sale! Get up to 30% off detailed market research reports—for a limited time only! LONDON, GREATER LONDON, UNITED KINGDOM, December 4, 2024 /⁨EINPresswire.com⁩/ -- The Business Research Company’s Early …

Latest: Household Insecticides Market is Booming Worldwide at a Significant Growth by 2032

The global household insecticides market is projected to reach $31.1 billion by 2032, growing at a CAGR of 7.5% from 2023 to 2032. WILMINGTON, DE, UNITED STATES, December 4, 2024 /⁨EINPresswire.com⁩/ -- According to the report, the global …